Quick Answer
Pelthos Therapeutics Inc. reported Total Assets of $130.40 million for fiscal year 2025.
Pelthos Therapeutics Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $130.40M | +9425.0% |
| 2024 | $1.37M | +1320.3% |
| 2023 | $96.4K | +75.0% |
| 2022 | $55.1K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $126.43M | +5808.4% | +15265.3% |
| June 30, 2025 | $822.9K | -68.4% | -9.7% |
| March 31, 2025 | $911.2K | -77.4% | -33.4% |
| December 31, 2024 | $1.37M | +1320.3% | -36.0% |
| September 30, 2024 | $2.14M | — | -17.8% |
| June 30, 2024 | $2.60M | — | -35.4% |
| March 31, 2024 | $4.03M | — | +4082.5% |
| December 31, 2023 | $96.4K | — | — |
- Pelthos Therapeutics Inc. showed an increase of +9425.0% in Total Assets compared to the prior fiscal year.
- Over the 2022–2025 period, Pelthos Therapeutics Inc.’s total assets has grown by 236666.9% (from $55.1 thousand to $130.40 million).
- The most recent figure is from Pelthos Therapeutics Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: